El-Khoueiry, A. B., Rankin, C. J., Ben-Josef, E., Lenz, H., Gold, P. J., Hamilton, R. D., . . . Blanke, C. D. (2011). SWOG 0514: A phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma.
Chicago Stili AlıntıEl-Khoueiry, Anthony B., Cathryn J. Rankin, Edgar Ben-Josef, Heinz-Josef Lenz, Philip J. Gold, R. Darryl Hamilton, Rangaswamy Govindarajan, Cathy Eng, ve Charles D. Blanke. SWOG 0514: A Phase II Study of Sorafenib in Patients With Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma. 2011.
MLA AlıntıEl-Khoueiry, Anthony B., et al. SWOG 0514: A Phase II Study of Sorafenib in Patients With Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma. 2011.